Successful treatment of PLA2R1-antibody positive membranous nephropathy with ocrelizumab. Schmidt T, Schulze M, Harendza S, Hoxha E, et al. J Nephrol 2020 Oct 7. pii: 10.1007/s40620-020-00874.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schmidt T, Schulze M, Harendza S, Hoxha E, et al. Successful treatment of PLA2R1-antibody positive membranous nephropathy with ocrelizumab. J Nephrol 2020 Oct 7. pii: 10.1007/s40620-020-00874.
PMID: 33026632